Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zohre Miri Lavasani"'
Autor:
Mahsa Salehi, Zohre Miri Lavasani, Hani Keshavarz Alikhani, Bahare Shokouhian, Moustapha Hassan, Mustapha Najimi, Massoud Vosough
Publikováno v:
Cells, Vol 12, Iss 18, p 2260 (2023)
Liver cancer is a significant contributor to the cancer burden, and its incidence rates have recently increased in almost all countries. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is the second leading cause of
Externí odkaz:
https://doaj.org/article/fe41cc4d1b29457697abc28a64d17093
Autor:
Mahsa Ghasemzad, Mahdieh Hashemi, Zohre Miri Lavasani, Nikoo Hossein-khannazer, Haleh Bakhshandeh, Roberto Gramignoli, Hani Keshavarz Alikhani, Mustapha Najimi, Saman Nikeghbalian, Massoud Vosough
Publikováno v:
Bioengineering, Vol 9, Iss 8, p 392 (2022)
The majority of monogenic liver diseases are autosomal recessive disorders, with few being sex-related or co-dominant. Although orthotopic liver transplantation (LT) is currently the sole therapeutic option for end-stage patients, such an invasive su
Externí odkaz:
https://doaj.org/article/e8294e78e3284d7e9051462324bd51ce
Autor:
Zohre Miri-Lavasani, Shukoofeh Torabi, Roya Solhi, Bahareh Shokouhian, Parvaneh Afsharian, Zahra Heydari, Abbas Piryaei, Zahra Farzaneh, Nikoo Hossein-khannazer, Hamidreza Aboulkheyr Es, Ensieh Zahmatkesh, Andreas Nussler, Moustapha Hassan, Mustapha Najimi, Massoud Vosough
Publikováno v:
Stem Cells International, Vol 2022 (2022)
Background. A growing number of hepatocellular carcinoma (HCC), and recurrence frequency recently have drawn researchers’ attention to alternative approaches. The concept of differentiation therapies (DT) relies on inducing differentiation in HCC c
Externí odkaz:
https://doaj.org/article/a244842833be49c5a9cee36ec7c50d94
Autor:
Niloufar Rezaei, Mandana Kazem Arki, Zohre Miri-Lavasani, Roya Solhi, Mahsa Khoramipour, Hamid Rashedi, Hamid Asadzadeh Aghdaei, Nikoo Hossein-Khannazer, Ebrahim Mostafavi, Massoud Vosough
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 188:33-47